Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Gaskins Tammi L, holds the title of Chief Commercial Officer at IRONWOOD PHARMACEUTICALS INC.
On 2026-11-16, the insider transacted 5,919 shares.The shares were transacted at a weighted average price of $4.81 per share, resulting in a total market-relevant value of $28K.
Gaskins Tammi L (Chief Commercial Officer) sold $28K of $IRWD
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.